Following US FDA approval (see here) Israel’s Redhill has launched its Talicia treatment for H.pylori (Helicobacter) infections in the US. RedHill’s expanded sales force will promote Talicia to approximately 25,000 gastroenterologists, primary care physicians and other healthcare providers.
https://www.israel21c.org/israeli-pharma-company-launches-drug-for-h-pylori-in-us-market/